| TNRAX | VIGAX | TNRAX / VIGAX | |
| Total Expense Ratio | 0.90 | 0.05 | 1,800% |
| Annual Report Gross Expense Ratio | 1.04 | 0.05 | 2,080% |
| Fund Existence | 3 years | 26 years | - |
| Gain YTD | 8.158 | 7.482 | 109% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 214M | 379B | 0% |
| Annual Yield % from dividends | 0.00 | 0.38 | - |
| Returns for 1 year | 17.41 | 18.72 | 93% |
| Returns for 3 years | N/A | 81.36 | - |
| Returns for 5 years | N/A | 78.70 | - |
| Returns for 10 years | N/A | 374.92 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GTMUX | 25.99 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Growth R6 | |||
| VLCAX | 175.58 | N/A | N/A |
| Vanguard Large Cap Index Admiral | |||
| MASKX | 32.18 | N/A | N/A |
| iShares Russell 2000 Small-Cap Idx Instl | |||
| TRZYX | 24.28 | N/A | N/A |
| T. Rowe Price Latin America Z | |||
| MCYIX | 16.37 | -0.51 | -3.02% |
| NYLI Candriam Emerging Markets Eq Cl I | |||